Fig. 2.
Effect of Bcl-2-AS on the viability of HL-60 and HL-60-DOX cells as determined by MTS assay.
The viability of HL-60 cells and HL-60-DOX–resistant cells was effectively reduced by Bcl-2-AS in a dose-dependent fashion (IC50 = 4 and 10 μmol/L, respectively). NS and empty liposomes (EL) did not effect the cell viability.
